Frost & Sullivan Applauds Calgary Scientific for its Focus on Maximizing Operational Efficiency and Fine Tuning its Execution Capabilities
-- Calgary Scientific's products have advanced technologies, which meet the global demand in the new-era medical diagnosis paradigm
MOUNTAIN VIEW, California, Sept. 8, 2015 /PRNewswire/ -- Based on its recent analysis of the medical imaging informatics market, Frost & Sullivan recognizes Calgary Scientific Inc. with the 2014 North American Frost & Sullivan Award for Growth Capital Investment Opportunity. With its path-breaking, patented technology, global original equipment manufacturer (OEM) channels, and a proven track record of product sales, Frost & Sullivan expects Calgary Scientific to increase its market share and revenue growth in the near future.
Click here for the full multimedia experience of this release - http://bit.ly/1MIw8Rl
Calgary Scientific thrives on continuous innovation of patentable technologies as well as direct integration with global partners. Its next-generation web, cloud, mobility, and enterprise-class software applications are currently offered through the PureWeb® and ResolutionMD® product lines, with two more cloud and collaboration products set to be launched in Q1 2015.
Through PureWeb®, traditional legacy modernization and back-end enterprise systems integration are made less risky, less costly, and dramatically more rapid, as no source code must be modified during the PureWeb enablement process. Similarly, through ResolutionMD®, medical professionals can securely locate and utilize patient images and reports, as well as a variety of other data and file types, from diverse computers and mobile devices. It also enables them to collaborate in real time with other practitioners and enable more accurate, fully FDA Class II-accredited medical diagnosis from any location.
The company currently holds 22 issued and more than 145 pending patents for its technologies, including more than 50 unique patent families, many filed globally. This represents a highly impressive patent portfolio of unique intellectual property, as most rival software companies have one or two patents, if any at all.
"Importantly, Calgary Scientific Inc.'s extremely capable management team boasts the right combination of experience, expertise and decision-making capabilities," said Frost & Sullivan Senior Research Analyst Dr. Saneesh Edacherian. "Owing to its combined expertise, Calgary Scientific Inc. has been able to raise approximately $43 million as of June 2014 through seven rounds of equity funding and $5 million in debt funding."
To date, Calgary Scientific Inc. has signed close to 50 global OEM/white label partners and OEM resellers, including Siemens, Fuji, Hitachi Data Systems, Yokogawa, Dajia, Infinitt, Hyland Software, and Allscripts. These partnerships are a mix of the top-tier players and very strong local/regionalized players around the globe.
Between 2012 and 2013, Calgary Scientific Inc. grew by more than 50 percent year over year in revenues. The company is consistently striving to be on target in revenues, and has managed to achieve a year-on-year growth rate of over 107 percent over 2013.
"The company employs a two-pronged approach to increase its clientele and improve its product offerings. It consistently engages with new OEMs in new geographies as well as existing partners in new geographies," noted Edacherian. "It is also currently expanding its business to encompass computer-aided design and engineering divisions with the projected launch of its own web/cloud, mobile and collaboration-enabled version of a CAD product."
Each year, Frost & Sullivan presents this award to the company that demonstrates outstanding operation and execution capabilities, backed by a management team with a successful track record, ability to execute, and considerable industry experience. The award recipient has in place a solid expansion and positioning strategy, and outperforms its rivals in funding history as well as the strength and quality of additional investors.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
To read to full best practices report, visit www.calgaryscientific.com/frost-sullivan
About ResolutionMD®
ResolutionMD enables doctors to securely view patient images and reports from a wide variety of computers and mobile devices, collaborate with other practitioners and diagnose from any location. Whether you are a single facility or a large healthcare system with tens of thousands of users, ResolutionMD is the best choice for seamless image access across multiple departments. The FDA cleared, CFDA certified, Health Canada licensed, CE marked and TGA certified mobile medical diagnosis software can be integrated into any EMR and easily plugs into existing distributed storage systems. ResolutionMD's federated approach is an important differentiator from other solutions as highly sensitive data is never moved to a device and no additional data storage locations are created. ResolutionMD is published in 12 languages and is currently installed in leading healthcare institutions around the world via a network of more than 45 world class OEM healthcare partners. For more information on ResolutionMD, go to http://www.calgaryscientific.com/resolutionmd.
About Calgary Scientific Inc.
Calgary Scientific is the global leader in web and mobile diagnostic medical imaging solutions and collaboration enablement technologies. For more information on Calgary Scientific, go to http://www.calgaryscientific.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact:
Mireya Espinoza
P: +1.210.247.3870
F: +1.210.348.1003
E: [email protected]
Press contact:
Jennifer Sobotka
Calgary Scientific Inc.
Director of Marketing
[email protected]
(+1) 403.767.7941
Investor contact:
Byron Osing
Calgary Scientific Inc.
CEO and Chair
[email protected]
(+1) 403.767.7959
Share this article